Stellaris Venture Partners

Stellaris Venture Partners is one of India’s most disciplined early-stage venture firms, headquartered in Bengaluru with multiple funds totalling over $300M cumulatively, deploying $1M-$5M cheques at Seed and Series A. The firm has built a sharp healthcare portfolio anchored by Carpl in radiology AI integration and mFine in digital health, signalling deep conviction in AI adoption within Indian clinical workflows alongside specialised digital health plays. For founders, Stellaris is best positioned as a category-leading early lead for Indian founders building AI-enabled clinical software, digital health platforms, and health IT infrastructure with strong product-market fit signals and ambitions to scale across India and globally. The right founder profile is a technically credible Indian operator with founder-market fit, paid customer signal, and a clear thesis on AI adoption within radiology, pathology, RCM, or clinical workflow. Founders running consumer wellness, asset-heavy clinic models, or pre-product experiments are a poor fit. The cleanest entry path is via a Stellaris portfolio CEO (Carpl, mFine, Whatfix, Mamaearth, Slintel, Propelld), the SaaSBOOMi network, or warm introductions from US-based funds that co-invest at Series A and B. In the pitch, lead with hospital or payer logos, clinical adoption evidence, ARR or revenue traction, and a credible Series B plan that names likely international leads (Sequoia, Lightspeed, Tiger). Caveats: Stellaris runs a disciplined process with deep customer and reference checks, and partners are technically sharp on AI, so model claims will be probed rigorously. Cycle times can be months for healthcare AI given the diligence depth. Confirm reserves and follow-on policy explicitly given the firm’s concentrated position approach.